Besides, results of IHC assay also indicated that KLF13 obviously inhibited Ki67 expression, along with down-regulating the protein expressions of β-catenin and its downstream Cyclin D1 and c-Myc in tumor tissues (Fig. 6E). The gene discussed is KLF13; the disease is neoplasm.